Watch Live: Supreme Court weighs legality of Purdue Pharma bankruptcy settlement
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Watch live as the Supreme Court hears arguments around the legality of OxyContin maker Purdue Pharma’s bankruptcy settlement, on 4 December 2023.
As part of the Sackler Family’s deal to give up ownership of drug manufacturer Purdue Pharma, and for contributing $6 billion to fight the opioid crisis, members of the wealthy family would be exempt from civil lawsuits. They may potentially be able to keep billions in profits.
The Supreme Court will hear whether the agreement violates federal law. They’ll also ponder the issue of whether the legal shield that bankruptcy provides can or should be given to people such as the Sacklers, who haven’t declared bankruptcy themselves.
Family members have generally stayed out of the public eye, and they have stood down from their firm’s board of directors and have not received any dividends since before the company went bankrupt.
However, in the decade before that, they were paid more than $10 billion, about half of which, according to family members, went into taxes.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments